Rutgers Global Health Institute director Richard Marlink‘s comments about vaccine efficacy are featured in a collection of health experts’ perspectives related to the U.S. Food and Drug Administration’s granting of emergency approval to Johnson & Johnson’s one-shot COVID-19 vaccine. The following is an excerpt from the story published by ROI-NJ:

“When you add a vaccine that is this effective to what our bodies can do already, this vaccine is a home run.”

Dr. Richard Marlink, the director of Rutgers Global Health Institute, said you can’t judge a vaccine by its efficacy rate because of the variables involved — including this: We still don’t know the length of effectiveness of any of the vaccines — is it six months or many years?

As someone who has spent a lifetime in this field, Marlink said all of the efficacy numbers are outstanding.

“These are all home-run vaccines,” he said. “You’re looking at the difference between a BMW and a Mercedes. They’re both unbelievably wonderful cars — and both are not just going to get me where I need to go, they’re going to get me there in style. This is not the difference between the old Pinto and a Cadillac.”

The key, of course, is getting everyone behind the wheel.

Read the full story at